Skip to content

Market access and HEOR consultants for payer evidence and pricing work.

Payers decide whether patients get your product. Find consultants who have built value dossiers, economic models and payer strategies for US launches, and bring them in at the point your evidence plan needs them.

  • Rates on every profile
  • No company-side fee
  • Contract directly

What market access and HEOR consultants take on

Common market access and heor work companies hire for.

01

Payer strategy

Access strategy, payer research and value proposition testing.

02

Value dossiers

AMCP format dossiers and global value dossiers.

03

Economic models

Cost-effectiveness and budget impact models with documentation.

04

Evidence planning

Integrated evidence plans and real-world evidence study design.

05

Pricing

Pricing research, analogue analysis and launch price corridors.

06

Payer materials

Objection handlers and materials for account teams.

Typical engagements

What a project usually looks like.

Lengths are typical ranges for each scope, not commitments. You agree the actual timeline with the consultant.

ScopeTypical lengthFormat
AMCP dossier for a US launch8 to 12 weeksRemote
Budget impact model6 to 10 weeksRemote
Payer advisory board and research4 to 8 weeksHybrid
Early access and pricing assessment3 to 6 weeksRemote
Fractional market access lead1 to 2 days a week, ongoingRemote

Fractional vs full-time

When a fractional market access consultant makes sense.

  • You are planning Phase III and want payer evidence built into it.
  • You need a dossier or a model, not a market access department.
  • A launch is coming and pricing work has not started.
  • You want an independent check on a vendor's model.

Before you hire

Questions worth asking.

  • US payers, ex-US HTA, or both?
  • Have they built models themselves, or managed modelling vendors?
  • Which therapeutic areas and which kinds of products: specialty, rare disease, primary care?
  • Experience with launches that reached formulary decisions?
  • Can they explain a model's assumptions to a non-economist?
Market access consultant presenting a payer strategy

Hiring on FindPharmaPros

Read the profile, then talk to the consultant.

Every market access consultant profile shows specialties, therapeutic areas, the work behind them, availability and an hourly rate. Message the people you want to talk to and agree scope and terms directly. Companies pay no platform fee; consultants pay a flat 9.5% on invoiced work.

Hiring market access and HEOR consultants

Questions hiring teams ask.

Health economics and outcomes research. It produces the evidence payers use to judge value: cost-effectiveness and budget impact models, patient-reported outcomes and real-world evidence.

Ideally while Phase III is being designed, so the trial collects the outcomes payers will ask about. Many companies bring in a fractional market access lead at that point.

Yes. A budget impact model or an AMCP dossier is a well defined deliverable and suits a project engagement.

Some do. Profiles list the markets and agencies each consultant has worked with.

Consultants publish their rates. You agree scope and fees directly, and companies pay no platform markup.

Are you a market access consultant?

Create a free profile and let companies looking for your experience contact you.

Find your market access consultant today.

Open profiles, published rates, direct messages. No intake call.